There is some good budgetary news as it now appears that the CDMRP (the Department of Defense) programs, including the Peer Reviewed Prostate Cancer Program, are funded at the omnibus level (last year’s level).

The bill has not yet passed and is still vulnerable to changes. As of today, this is how the budget looks:

RESEARCH AND DEVELOPMENT

— ALS — +8,000

— Armed Forces Institute of Regenerative Medicine — +4,800

— Autism Research — +6,400

— Bone Marrow Failure Disease Research Program — +4,000

— Duchenne Muscular Dystrophy — +4,000

— Global HIV/AIDS Prevention — +10,000

— Traumatic Brain Injury and Psychological Health — +100,000

—Global Deployment of the Force medical research funding –

— Department of Defense requested transfer to maintain full

funding for the program — +125,000

— Gulf War Illness Peer-Reviewed Research Program — +8,000

— Multiple Sclerosis — +4,800

— Peer-Reviewed Alzheimer Research — +15,000

— Peer-Reviewed Breast Cancer Research Program — +150,000

— Peer-Reviewed Cancer Research Program — +16,000

— Peer-Reviewed Lung Cancer Research Program — +12,800

— Peer-Reviewed Orthopedic Research Program — +24,000

— Peer-Reviewed Ovarian Cancer Research Program — +20,000

— Peer Reviewed Vision research in conjunction with the DoD

— Vision Center of Excellence — +4,000

— Peer-Reviewed Prostate Cancer Research Program — +80,000

— Peer-Reviewed Spinal Cord Research Program — +12,000

— Research in Alcohol and Substance Use Disorders — +5,200

— SBIR to the core funded RDT&E — +1,200

— Tuberous Sclerosis Complex (TSC) — +6,400

— Pain Management Task Force Research — +4,000

— Peer Reviewed Medical Research Program — +50,000

— Neurofibromatosis Research — +16,000

Joel T. Nowak,  M.A., M.S.W.